get a key
steadybase-$ person Mark Hahn
nameMark Hahn
roleCFO
company Verona Pharma plc VRNA
linkedin none on file
contactnot published
filingsnone on file
quotes
In addition, marketing and other commercial-related activities, including travel, increased by $7.5 million, and professional and consulting fees, information technology costs, and other related support costs, increased by $1.6 million, as we continue to build out our organization.

Nov 4, 2024 / CFO / receipt, needs a key / Mark Hahn, CFO | earnings call 2024-11-04 | transcript 681716b9-7bb0-4167-a66b-8d3b95556032 | chars 8447-8729 | segment 8

This increase was driven primarily by a $15.6 million increase in people-related costs as we expanded our headcount with key hires in medical affairs and commercial positions, inclusive of share-based compensation, as well as an increase of $9.7 million related to the build out of the commercial and information technology infrastructures, marketing and market development expenses, and costs associated with our medical affairs team's increased presence at local, regional, and national medical conferences.

Feb 29, 2024 / CFO / receipt, needs a key / Mark Hahn, CFO | earnings call 2024-02-29 | transcript 593e2f73-7df4-4796-8436-dc683ee35f57 | chars 9837-10346 | segment 9

steadybase-$